Medicare Part D coverage · 0.56 · RxCUI 2693643
0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath]
Per the CMS 2026 Part D formulary file, 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] is covered by 142 Medicare Part D plans (2.8% of enrollable products), averaging Tier 4.2, with prior authorization required on 100% of covering formularies.
- 2.8%
- Plan coverage
- 142
- Plans covering
- T4.2
- Avg tier
- 100%
- Prior auth required
What the CMS Formulary Data Shows for 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath]
Per the CMS 2026 Part D formulary file, 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] (RxNorm concept RXCUI 2693643, generic name 0.56) appears on 29 distinct formulary files spanning 142 Medicare Part D plan offerings - 2.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 58.6% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] today.
Coverage Details
- Formularies covering
- 29
- Plans covering
- 142
- Coverage rate
- 2.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 58.6% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue Plus PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] covered by Medicare Part D?
Yes, 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] is covered by 142 Medicare Part D plans (2.8% of all Part D formularies).
What tier is 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] on Medicare Part D plans?
0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] require prior authorization?
100% of Part D formularies require prior authorization for 0.56 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath]. Step therapy: 0%. Quantity limits: 58.6%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- everolimus 10 MG Oral Tablet T4.2
- {56 (elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack [Trikafta (50 MG / 37.5 MG / 25 MG; 75 MG)] T4.2
- 1.5 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] T4.2
- alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin] T4.2
- ivacaftor 150 MG Oral Tablet [Kalydeco] T4.2
- tenofovir alafenamide 25 MG Oral Tablet [Vemlidy] T4.2
Similar prior-authorization rate
- azathioprine 50 MG Oral Tablet 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- sotagliflozin 200 MG Oral Tablet [Inpefa] 100% PA
- mycophenolate mofetil 250 MG Oral Capsule 100% PA